CJC-1295 with DAC vs without DAC — understanding the half-life difference

CJC-1295 with and without DAC represent two different approaches to GH secretagogue research, each with distinct advantages and trade-offs. Understanding these differences is essential for protocol selection.

CJC-1295 with DAC (Drug Affinity Complex):
The DAC modification extends the half-life dramatically — from minutes to approximately 6-8 days. This means a single injection provides sustained GH release over nearly a week. The advantage is convenience (less frequent injections). The disadvantage is loss of the natural pulsatile pattern of GH release. The body normally releases GH in pulses, and some researchers believe maintaining this pulsatile pattern is important for optimal results.

Typical protocol: 2mg once or twice weekly. Some researchers report water retention and elevated hunger as side effects, likely due to sustained elevation rather than pulsatile release.

CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF):
Without the DAC, the half-life is approximately 30 minutes. This requires more frequent dosing — typically 2-3 times daily. However, each injection creates a natural-looking GH pulse rather than sustained elevation. Most researchers pair it with a GHRP (like ipamorelin or GHRP-2) to amplify each pulse.

Typical protocol: 100mcg Mod GRF + 100mcg ipamorelin, 2-3 times daily (morning, post-workout, before bed).

Which is better for research:
The community generally favors CJC-1295 without DAC (Mod GRF) paired with ipamorelin. The reasoning: pulsatile GH release more closely mimics natural physiology, side effects tend to be milder, and the combination with ipamorelin creates a synergistic pulse greater than either alone. The trade-off is injection frequency.

CJC-1295 with DAC has merit for researchers prioritizing convenience and who do not mind sustained elevation. Some bodybuilding-focused researchers prefer it for the consistent IGF-1 elevation.

Critical note on vendor sourcing:
"CJC-1295 no DAC" and "Modified GRF 1-29" should be identical compounds, but vendor labeling is inconsistent. Always verify by checking the amino acid sequence on the COA. The correct sequence for Mod GRF 1-29 is: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2.

If the COA does not list the sequence, that itself is a flag worth investigating.